Literature DB >> 11257152

Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis.

I Pasquali Ronchetti1, D Guerra, F Taparelli, F Boraldi, G Bergamini, G Mori, F Zizzi, L Frizziero.   

Abstract

OBJECTIVE: The study was part of a randomized open-label clinical trial designed to evaluate the effects of intra-articular injections of hyaluronan (Hyalgan) (HY) in osteoarthritis (OA) of the human knee. Data were compared with those obtained after treatment with methylprednisolone acetate (Depomedrol) (MP).
METHODS: Synovial membranes from patients with OA of the knee, primary or secondary to a traumatic event and classified according to the American College of Rheumatology criteria, were examined by arthroscopy and by light and electron microscopy before and 6 months after local injection of HY (2 ml of 500-730 000 MW hyaluronan, 10 mg/ml in saline, one injection per week for 5 weeks) or MP (1 ml of methylprednisolone acetate, 40 mg/ml, one injection per week for 3 weeks).
RESULTS: Arthroscopy revealed a significant decrease in inflammatory score after both treatments. Histology showed that HY treatment was effective (P< or =0.05) in reducing the number and aggregation of lining synoviocytes, as well as the number and calibre of the vessels. MP treatment significantly reduced the number of mast cells in primary OA. Both treatments tended to decrease the number of hypertrophic and to increase the number of fibroblast-like lining cells, to decrease the numbers of macrophages, lymphocytes, mast cells and adipocytes, and to decrease oedema, especially in primary OA, and to increase the number of fibroblasts and the amount of collagen. These phenomena were evident throughout the thickness of the synovial tissue.
CONCLUSION: At least in the medium term, both HY and MP modified a number of structural variables of the synovial membrane of the osteoarthritic human knee towards the appearance of that of normal synovium. The effect was more evident in primary OA than in OA secondary to a traumatic event. This is the first evidence that local hyaluronan injections modify the structural organization of the human knee synovium in OA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257152     DOI: 10.1093/rheumatology/40.2.158

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  27 in total

Review 1.  Potential applications of hyaluronans in orthopaedics: degenerative joint disease, surgical recovery, trauma and sports injuries.

Authors:  Michael J Axe; Clarence L Shields
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis.

Authors:  Nurdan Kotevoglu; Pinar Cakil Iyibozkurt; Ozcan Hiz; Hasan Toktas; Banu Kuran
Journal:  Rheumatol Int       Date:  2005-06-15       Impact factor: 2.631

3.  Intra-articular hylastan versus steroid for knee osteoarthritis.

Authors:  Lawrence Housman; Nigel Arden; Thomas J Schnitzer; Charles Birbara; Thierry Conrozier; Nebojsa Skrepnik; Nathan Wei; Barry Bockow; David Waddell; Hasan Tahir; Anthony Hammond; Philippe Goupille; Bernd-Jan Sanson; Clare Elkins; François Bailleul
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-02-16       Impact factor: 4.342

4.  Six-months pain relief and functional recovery after intra-articular injections with hyaluronic acid (mw 500-730 KDa) in trapeziometacarpal osteoarthritis.

Authors:  Antonio Frizziero; Nicola Maffulli; Stefano Masiero; Luigi Frizziero
Journal:  Muscles Ligaments Tendons J       Date:  2014-07-14

Review 5.  Effectiveness and utility of hyaluronic acid in osteoarthritis.

Authors:  Alberto Migliore; Simone Procopio
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

6.  Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis.

Authors:  A R Shikhman; D Amiel; D D'Lima; S-B Hwang; C Hu; A Xu; S Hashimoto; K Kobayashi; T Sasho; M K Lotz
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

7.  Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate.

Authors:  A Alam; Alka Ahuja; Sanjula Baboota; S K Gidwani; J Ali
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

Review 8.  Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis.

Authors:  Egemen Ayhan; Hayrettin Kesmezacar; Isik Akgun
Journal:  World J Orthop       Date:  2014-07-18

9.  Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder osteoarthritis: a prospective multicenter, open-label trial.

Authors:  Giuseppe Porcellini; Giovanni Merolla; Nicola Giordan; Paolo Paladini; Andrea Burini; Eugenio Cesari; Alessandro Castagna
Journal:  Joints       Date:  2016-01-28

Review 10.  Local effects of intra-articular corticosteroids.

Authors:  George S Habib; Walid Saliba; Munir Nashashibi
Journal:  Clin Rheumatol       Date:  2010-01-26       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.